eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 10
 
Share:
Share:
Original paper

Endoscopic band ligation versus hot snare resection for hyperplastic gastric polyps in cirrhotic patients

Maha Elsabaawy
1
,
Osama Elbahr
1
,
Ahmed Edrees
1
,
Reda Badr
1
,
Ahmed Kamal
1
,
Sameh Afify
1

1.
Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El Koum, Menoufia, Egypt
Clin Exp HEPATOL 2024; 10, 1: 14–19
Online publish date: 2024/03/17
Article file
- Endoscopic.pdf  [0.11 MB]
Get citation
 
PlumX metrics:
 

Introduction

Gastric hyperplastic polyps (GHPs) represent 30% to 93% of all gastric epithelial polyps [1]. They are characterized by dilated, elongated, tortuous foveolae (which impart the corkscrew appearance) lined by hyperplastic gastric mucin-containing epithelium [1]. Both the epithelium and mesenchymal stromal cells can show marked regenerative changes. Many factors such as Helicobacter pylori infection, chronic atrophic gastritis, portal hypertension, autoimmune gastritis and gastric surgery have been defined as risk factors for GHPs [2]. Most hyperplastic gastric polyps occur as single lesions; however, multiple polyps may also occur in 20% of cases [3]. The size of GHPs vary from a few millimeters to several centimeters [3]. They can occur in different parts of the stomach, including the body, fundus and gastroenteric anastomoses with or without antrum involvement [4].

Gastric hyperplastic polyps were noted in almost 1% of cirrhotic patients undergoing routine esophagogastroduodenoscopy (EGD) and can cause upper gastrointestinal bleeding leading to anemia [5]. The term portal hypertensive polyps (PHPs) has been used to describe GHPs in the context of cirrhosis [6]. Endoscopically, GHPs might present as reddish, slender, tandem with an earthworm like swelling on the surface and a remarkable increase of surface capillary vessels [4, 7]. Dysplasia in GHPs may develop from them and are found in up to 19%, and adenocarcinoma has been reported in about 2.1% of resected polyps. The risk is strongly associated with the size, an observation that has led to the recommendation of removal of polyps larger than 5 mm or 10 mm [8].

The standard treatment for PHPs > 10 mm is polypectomy. Resection of GHPs in cirrhotic patients by polypectomy is associated with a high risk of the bleeding disorder referred to as coagulopathy, complicating hepatic dysfunction, and portal hypertension induced thrombocytopenia [2, 3].

Hot snare polypectomy (HSP) is the most acceptable procedure for HP resection despite the high rate of complications (bleeding and perforation) which have been reported in a range of 2.7% to 23.9% [8]. Although there are several preventive measures, post-polypectomy hemorrhage remains a major complication of polypectomy until now, especially in patients with liver cirrhosis [9].

Endoscopic band ligation (EBL) by suction equipment and rubber bands has been used to eradicate esophageal varices in patients with cirrhosis related portal hypertension [10].

In the literature, a few studies and one case report have evaluated EBL as proper management of GHPs even in presence of bleeding or bleeding liability [1114].

In this study, we aimed to assess the efficacy of EBL for GHP resection in patients with liver cirrhosis.

Material and methods

Study design

This is a single-center prospective study carried out at the National Liver Institute (NLI), Menoufia University. Eligible patients aged ≥ 18 years were enrolled between October 2018 and October 2020.

Informed consent was taken and GHPs detected through EGD in cirrhotic patients were evaluated within the scope of our study. Findings such as esophageal and/or gastric varices, ascites, splenomegaly, and portal hypertensive gastropathy are diagnostic for the presence of portal hypertension [6]. Multiple bio-psies were taken from all polyps for histopathological assessment. The histological diagnostic criteria of GHPs were set as the presence of foveolar hyperplasia with an inflammatory and abundant chorion or long, deep, and hypersecreting crypts [7].

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of National Liver Institute, Menoufia University (NLI IRB OOOO3413 FWAOOOO227).

Demographic, clinical, and endoscopic variables

Demographic and clinicopathologic data were retrieved including age, gender, symptoms, etiology of liver disease, and CTP score of cirrhosis. Endoscopic data, i.e., GHP number, size, location, and morphology, were collected from EGD reports. Operation details including operating time, established blood loss, complications, interventions, number of sessions and recurrence were also recorded. Perforation or hemorrhage was considered as a complication of the procedure. The hospitalization expenses mainly consisted of the cost of the procedure and that of perioperative care. Upper endoscopy was repeated for all patients at 3-, 6- and 12-month post-treatment time points for recurrence.

All endoscopic resections were done by experienced endoscopists using the standard method. All patients were informed of the benefits and risks of the procedure. Eligible polyps were randomized (1 : 1) to be managed with either EBL or HSP.

EBL procedure

Endoscopic band ligation is done using a banding device attached to the tip of the endoscope. The polyp is sucked into the banding chamber, and a trip wire dislodges a rubber band ligating the entrapped polyp [4].

HSP procedure

Hot snare polypectomy is a minimally invasive endoscopic procedure used to remove polyps from the upper gastrointestinal tract. During the procedure, the endoscope is inserted through the mouth and into the esophagus and stomach. The camera on the end of the scope allows visualization of the polyp. A snare wire loop is passed through the endoscope and positioned around the base of the polyp and tightened, allowing it to be removed from the body. Cauterization is used to prevent bleeding and reduces the risk of complications.

Outcomes: The primary outcome of the current study was the efficacy of EBL maneuvers and secondary outcomes were complication rates, polyp retrieval rates, and procedure time.

Statistical analysis

Data were collected, tabulated, and analyzed statistically using an IBM personal computer with SPSS Statistics version 20 (IBM, Chicago, Illinois, USA). Quantitative data were presented as mean, standard deviation (SD), and range, and qualitative data were presented as numbers and percentages. The chi-square test (χ2) was used to study the association between two qualitative variables. The t-test was used for comparison between two groups normally distributed having quantitative variables and the Mann-Whitney test used for comparison between two groups not normally distributed having quantitative variables. The significance level was set at a p value of < 0.05.

Results

Among the 100 cirrhotic patients in the current study, 50 received EBL and 50 received HSP randomly (1 : 1). As shown in Table 1, the demographic and clinical characteristics of the patients were balanced between the two study groups. The mean age of the included patients was 57.5 ±6.26 years in the EBL group and 59.6 ±5.83 years in the HSP group, p value = 0.080. The mean polyp size for the included patients was 1.46 ±0.42 cm in the EBL group and 1.52 ±0.45 cm in the HSP group, p value = 0.518. The mean number of polyps was 2.44 ±0.91 in the EBL group versus 2.12 ±0.89 in the HSP group, p value = 0.092. There was no significant difference in the morphology (p value = 0.317) and location (p value = 0.369) between the two groups (Table 1).

Table 1

Demographic and clinical characteristics of patients

VariablesEBLgroup
(n = 50)
HSP group
(n = 50)
Test of significanceP value
Age (years), mean ±SD57.5 ±6.2659.6 ±5.83t test = 1.760.080
Gender, n (%)
 Male30 (60)29 (58)χ2 = 0.0410.839
 Female20 (40)21 (42)
Child score, n (%)
 B17 (34)14 (28)/36 (36)χ2 = 04210.517
 C33 (66)
Symptoms, n (%)
 Anemia25 (50)27 (54)χ2 = 0.1600.689
 Bleeding25 (50)23 (46)
Number of polyps, mean ±SD2.44 ±0.912.12 ±0.89U = 1.680.092
Size of polyps (cm), mean ±SD1.46 ±0.421.52 ±0.45U = 0.6460.518
Morphology, n (%)
 Sessile22 (44)27 (54)χ2 = 1.000.317
 Pedunculated28 (56)23 (46)
Location, n (%)
 Antrum30 (60)26 (52)χ2 = 3.150.369
 Body13 (26)17 (34)
 Antrum and body2 (4)0 (0)
 Fundus5 (10)7 (14)

[i] n – number, χ2 – chi square test, U – Mann-Whitney test, SD – standard deviation

Endoscopic characteristics and clinical outcomes of patients treated with EBL or HSP (Table 2). The mean operating time was significantly shorter in patients who received EBL than patients received HSP (15.1 ±3.80 min vs. 36.6 ±6.72 min, p value < 0.001) (Fig. 1). Complications were significantly higher in the HSP group; 20% had bleeding (controlled by argon plasma coagulation (APC) in 8 patients and by combined APC and adrenaline injection in the other 2 patients) while no bleeding was reported in the EBL group (p = 0.003). The mean hospital cost was also significantly lower in the patients who received EBL (280.0 ±2.02 EGP) than those who received HSP (390.0 ±181.8 EGP), p value < 0.001. However, the recurrence in EBL and HSP patients during the follow-up period was 12% and 10%, respectively, with no significant difference (Table 2).

Fig. 1

Comparison between the studied groups regarding mean operation time

/f/fulltexts/CEH/52621/CEH-10-52621-g001_min.jpg
Table 2

Endoscopic characteristics and clinical outcomes of patients

VariablesEBL group
(n = 50)
HSP group
(n = 50)
Test of significanceP value
Operation time (min), mean ±SD15.1 ±3.8036.6 ±6.72U = 8.62< 0.001**
Complications, n (%)
 Pain3 (6)1 (2)χ2 = 11.70.003**
 Bleeding0 (0)10 (20)
 No47 (94)39 (78)
Amount of blood loss (ml), mean ±SD0 (0)7.10 ±5.86U = 8.52< 0.001**
Interventions for bleeding control, n (%)n = 10
 APC8 (80)
 APC and adrenaline2 (20)
Number of sessions, mean ±SD1.12 ±0.321.10 ±0.3U = 0.3180.750
Endoscopic recurrence, n (%)6 (12)5 (10)χ2 = 0.1020.749
Cost (EGP), mean ±SD280 ±2.02390 ±181.8U = 9.49< 0.001**

[i] N – number, χ2 – chi square test, U – Mann-Whitney test, APC – argon plasma coagulation, EGP – Egyptian pounds, SD – standard deviation

Discussion

Gastric hyperplastic polyps are incidentally discovered during screening, prophylactic, and therapeutic EGD in patients with portal hypertensive cirrhosis [4]. In patients with liver cirrhosis, the extensive mucosal damage and repair, antral hypercontraction and hypergastrinemia caused by proton pump inhibitor (PPI) abuse also might add more complexity [10]. Notably, despite the questionable potential precancerous liability, GHPs should be resected whenever incidentally detected [8].

The high rates of bleeding, both quantitative and qualitative, associated with HSP (the standard management maneuver) might represent a major concern especially in patients with liver cirrhosis [15].

Only a few studies have tried to investigate other procedures rather than HSP for resecting HPs with documented lower complication rates [4, 15, 16]. Despite the devaluation, the EBL seemed to be the perfect option for patients with liver cirrhosis to be done with esophageal varices band ligation in the same setting.

The current study assessed the efficacy of EBL, compared to the standard HSP for resecting GHPs in cirrhotic patients. Remarkedly, EBL performed greatly when considering the time needed to complete the procedure, which was found to be significantly shorter than the time for HSP (15.1 ±3.80 min vs. 36.6 ±6.72 min, p value < 0.001).

The expertise of the performer along with the specialized centers of excellence might add more professionalism and less impediments. However, bleeding was reported to be highly associated with HSP (20%) compared to null cases with bleeding in the EBL group of patients. These estimated rates of bleeding with HSP reported in the literature ranged from 1.0% to 7.2% in most studies [1720]. In the current study, the higher bleeding liability in cirrhotic patients is responsible for the high discrepancy rates when compared to other studies.

In snare polypectomy the cutting action of the snare loop may cause injury to blood vessels within or near the polyp base, leading to bleeding. Additionally, incomplete polyp removal [21], larger or more vascular polyps [22], and/or polyps located in rich blood supply areas were found to be associated with higher bleeding risk [23]. Lastly, the rare post-polypectomy syndrome characterized by abdominal pain, fever, and rectal bleeding occurring within 1-2 weeks after polypectomy is thought to be related to an inflammatory response following the procedure [24]. Occasionally, perforation of the bowel wall can occur during snare polyp resection and may result in significant bleeding [25]. Remarkedly, the risks of bleeding after a snare polypectomy are heightened in patients with chronic liver disease due to the accompanying thrombocytopenia, coagulation dysfunction, and portal hypertensive gastropathy with increased fragility of blood vessels [26]. However, these risks are minimized following polyp EBL even in patients with liver cirrhosis. The technique does not involve cutting or injuring blood vessels directly. The rubber band placement cuts off the blood supply gradually, at the polyp bases, which in a few minutes become congested and cyanotic with complete avascular necrosis leading to bloodless transection [27].

Additionally, the current study suggested that EBL is an effective modality in elective treatment of asymptomatic HPs as well as bleeding lesions. This is in accordance with a case report with bleeding GHP in a challenging uremic patient on antiplatelet therapy. A report documented the role of EBL as an efficacious measure in treating GHP in patients with high bleeding liability [28]. The advantages of EBL might include a bloodless biopsy even in patients with bleeding liabilities for avascular necrosis [12].

Moreover, patients with liver cirrhosis are always in need of upper endoscopy either for screening or therapeutic for esophageal varices allowing EBL for gastric polyps – if present – in the same session, conserving costs, time, and suffering.

The mean hospital cost was also significantly lower in the patients who received EBL than those who received HSP (280.0 ±2.02 vs. 390.0 ±181.8 EGP), p value < 0.001. Fruitfully, these reductions in the EBL cost might be more appropriate for patients with liver cirrhosis who were already financially exhausted.

The selection of the technique may be influenced by factors such as the polyp’s size and location, the presence of skilled professionals, and the availability of necessary equipment and expertise. EBL has shown better performance when dealing with different types of polyps (sessile or pedunculated), unlike HSP, which had a limited approach to the sessile polyps [28]. The EBL method allowed a lesion to be easily captured into the transparent hood, even in cases where it was situated tangentially and in sessile polyps.

Additionally, HSP is challenging when dealing with lesions in the lesser curvature, or the posterior wall and cardia of the stomach. On the other hand, EBL had a wide range of maneuverability whatever the lesion site [14].

Reportedly, EBL seems to be the ideal choice of bleeding GHP less than 1 cm in terms of technical difficulties, and HSP remains the only option for larger sizes [28].

However, the current study reports non-superiority of both maneuvers in treating GHP as regards size, number, or location.

To the best of our knowledge, this is the first study treating GHP in liver cirrhosis patients with high risk of bleeding by EBL. Notably, it proved efficacy, safety, shorter procedure time and lower cost, and added to the easy approach to any types of polyps. Advantageously, it can be done in the same setting with esophageal varices band ligation, which is done frequently in this category of patients, resulting in less suffering, lower costs, and higher safety. However, further validation of this maneuver in this critical cohort with large scale studies is still needed.

Disclosure

The authors declare no conflict of interest.

References

1 

Markowski A, Markowska A, Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol 2016; 22: 8883-8891.

2 

Jeong CY, Kim N, Lee HS, et al. Risk factors of multiple gastric polyps according to the histologic classification: Prospective observational cohort study. Korean J Gastroenterol 2019; 74: 17-29.

3 

Jain R, Chetty R. Gastric hyperplastic polyps: a review. Dig Dis Sci 2009; 54: 1839-1846.

4 

Polese L, La Raja C, Fasolato S, et al. Endoscopic diode laser therapy for gastric hyperplastic polyps in cirrhotic patients. Lasers Med Sci 2021; 36: 975-979.

5 

Yacoub H, Bibani N, Sabbah M, et al. Gastric polyps: a 10-year analysis of 18,496 upper endoscopies. BMC Gastroenterol 2022; 22: 70.

6 

Martín-Dominguez V, Diaz Mendez A, Santander C, Garcia Buey L. Portal hypertensive polyps, a new entity? Rev Esp Enferm Dig 2016; 108: 279-280.

7 

Kővári B, Kim B, Lauwers G. The pathology of gastric and duodenal polyps: current concepts. Histopathology 2021; 78: 106-124.

8 

João M, Areia M, Alves S, et al. Gastric hyperplastic polyps: A benign entity? Analysis of recurrence and neoplastic transformation in a cohort study. GE Port J Gastroenterol 2021; 28: 328-335.

9 

Nelson M, Ganger D, Keswani R, et al. Endoscopic resection is effective for the treatment of bleeding gastric hyperplastic polyps in patients with and without cirrhosis. Endosc Int Open 2016; 4: E874-E877.

10 

De Lisi S, Peralta S, Arini A, et al. Oesophagogastroduodenoscopy in patients with cirrhosis: extending the range of detection beyond portal hypertension. Dig Liver Dis 2011; 43: 48-53.

11 

Lo C, Hsu P, Lo G, et al. Endoscopic banding ligation can effectively resect hyperplastic polyps of the stomach. World J Gastroenterol 2003; 9: 2805-2808.

12 

Hsu P, Lai K, Tsay F, et al. Successful hemostasis, and resection of a bleeding gastric polyp by endoscopic banding ligation in a uremic patient taking antiplatelet agent. Springerplus 2016; 5: 1806.

13 

Chang FY. Endoscopic ligation for removal of stomach hyperptastic polyp: less risk or saving money. Zhonghua Yixue Zazhi (Taipei) 2001; 64: 615-616.

14 

Hsu PI, Lai KH, Lo GH, et al. Sequential changes of gastric hyperplastic polyps following endoscopic ligation. Zhonghua Yixue Zazhi (Taipei) 2001; 64: 609-614.

15 

Ket SN, Mangira D, Ng A, et al. Complications of cold versus hot snare polypectomy of 10-20 mm polyps: A retrospective cohort study. JGH Open 2019; 4: 172-177.

16 

Horiuchi A, Makino T, Kajiyama M, et al. Comparison between endoscopic mucosal resection and hot snare resection of large nonpedunculated colorectal polyps: a randomized trial. Endoscopy 2016; 48: 646-651.

17 

Lanza F, Graham D, Nelson R, et al. Endoscopic upper gastrointestinal polypectomy. Report of 73 polypectomies in 63 patients. Am J Gastroenterol 1981; 75: 345-348.

18 

Muehldorfer S, Stolte M, Martus P, et al. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut 2002; 50: 465-470.

19 

Chin-Lin Perng M, Li AFY, Full-Young Chang M, Shou-Dong Lee M. Is submucosal epinephrine injection necessary before polypectomy? A prospective, comparative study. Hepatogastroenterology 2001; 48: 1379-1382.

20 

Ji JS, Lee SW, Kim TH, et al. Comparison of prophylactic clip and endoloop application for the prevention of postpolypectomy bleeding in pedunculated colonic polyps: a prospective, randomized, multicenter study. Endoscopy 2014; 46: 598-604.

21 

Rex DK. Complications of colonoscopy. Gastrointest Endosc Clin N Am 2010; 20: 659-671.

22 

Hassan C, Repici A, Sharma P, et al. Efficacy and safety of endoscopic resection of large colorectal polyps: a systematic review and meta-analysis. Gut 2016; 65: 806-820.

23 

Paspatis GA, Tribonias G, Konstantinidis K, et al. Postpolypectomy bleeding during colonoscopy: predictors and role of polyp characteristics. Gastrointest Endosc 2004; 59: 662-667.

24 

Belderbos TDG, Leenders MWM, Baars JE, et al. Postpolypectomy bleeding after removal of large sessile colonic adenomas during anticoagulant therapy: a retrospective cohort study. Endoscopy 2018; 50: 1084-1092.

25 

Ma MX, Bourke MJ. Complications of endoscopic polypectomy, endoscopic mucosal resection, and endoscopic submucosal dissection in the colon. Best Pract Res Clin Gastroenterol 2016; 30: 749-767.

26 

Flores B, Trivedi HD, Robson SC, Bonder A. Hemostasis, bleeding, and thrombosis in liver disease. J Transl Sci 2017; 3: 10.15761/JTS.1000182.

27 

Topal F, Akbulut S, Karahanlı C, et al. Portal hypertensive polyps as gastroscopic finding in liver cirrhosis. Gastroenterol Res Pract 2020; 2020: 9058909.

28 

Lo C, Hsu P, Lo G, et al. Endoscopic banding ligation can effectively resect hyperplastic polyps of the stomach. World J Gastroenterol 2003; 9: 2805-2808.

Copyright: © 2024 Clinical and Experimental Hepatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.